Monographie - Filgrastim - Stabilis 4.0

Última actualização :
19/11/2024

Varios

Filgrastim

injetável

Estabilidade em soluções simples

Estabilidade em misturas

Factores que afectam a sua estabilidade

Compatibilidade

Método de administração

Bibliografía

pdf

Nomes comerciais nos diversos países

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Accofil	Alemanha, Bélgica, Gran-bretanha
Biocilin	México
Duperan	Chilli
Filgen	Argentina
Foltran	Chilli
Granulokine	Grècia, Itália
Hebervital	Colômbia
Inmunef	Colômbia
Leucosos	Colômbia
Lioplim	Chilli
Neupogen	Africa do sul, Austria, Bélgica, Croácia, Dinamarca, Eslovenia, Espanha, Estados Unidos de América, Finlandia, França, Gran-bretanha, Países Baixos, Polonia, Portugal, Suècia, Suicia, Turquia
Neutromax	Argentina
Neutropine	Argentina
Nivestim	Alemanha, Bélgica, França, Gran-bretanha, Noruega, Países Baixos
Ratiograstim	Alemanha, Austria, Gran-bretanha, Suècia
Tevagrastim	Alemanha, Gran-bretanha, Noruega, Países Baixos, Suècia, Suicia

Bibliografía

injetável

Bibliografía : Filgrastim

	tipo	publicação
99	jornal	Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
104	jornal	Hall PD, Yui D, Lyons S, Bosso JA. Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 185-189.
182	jornal	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
244	jornal	Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913.
2269	jornal	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3128	Laboratório	Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit Prostrakan 2013
3249	jornal	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3256	jornal	Burnett B, Radic I. Stability of Hospira filgrastim following changes to thermal and photic storage conditions. EJHP 2011 ; 17, 5: 49-56.
3474	Laboratório	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3618	Laboratório	Filgrastim (Neupogen®) - Summary of Product Characteristics Amgen 2014
3828	poster	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	poster	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	jornal	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4380	Laboratório	Posaconazole (Noxafil®) - Summary of Product Characteristics Merck Sharp & Dohme Limited 2019
4471	Laboratório	Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019 Kyowa Kirin Pharma 2019
4521	jornal	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020
4650	Laboratório	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021

Mentions Légales